tm logo
RULTYLO
Live/Registered
REGISTERED

on 07 May 2024

Last Applicant/ Owned by

3-5-1, Nihonbashi Honcho, Chuo-ku

Tokyo

JP

103-8426

Serial Number

97825177 filed on 06th Mar 2023

Registration Number

7378084 registered on 07th May 2024

in the Principal Register

Correspondent Address

Molly Hunsinger

Molly Hunsinger LADAS & PARRY LLP

CHICAGO, IL 60604

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

RULTYLO

Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97825177

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 3T23789007

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th May 2024REGISTERED-PRINCIPAL REGISTER
04th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Feb 2024PUBLISHED FOR OPPOSITION
31st Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31st Jan 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Jan 2024ELECTRONIC RECORD REVIEW COMPLETE
29th Dec 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
22nd Dec 2023APPROVED FOR PUB - PRINCIPAL REGISTER
21st Dec 2023TEAS/EMAIL CORRESPONDENCE ENTERED